Simon J. McGowan

Simon J. McGowan

Auto-generated profile, based on publicly available information

Simon J. McGowan

Computational Biology Research Group, MRC Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford OX3 9DS, UK

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 January 2014 in Nature Genetics
Verified
Journal Article
Closed access
JHJim R Hughes
Jim R Hughes
NRNigel Roberts
Nigel Roberts
SMSimon McGowan
Simon McGowan
DHDeborah Hay
Deborah Hay
Eleni GiannoulatouEleni Giannoulatou
Eleni Giannoulatou
DHDouglas R Higgs
Douglas R Higgs

18 May 2015 in Nature Genetics
Verified
Journal Article
Open access
PDF file
JTJenny Taylor
Jenny Taylor
HMHilary C Martin
Hilary C Martin
SLStefano Lise
Stefano Lise
JBJohn Broxholme
John Broxholme
JCJean-Baptiste Cazier
Jean-Baptiste Cazier
GMGilean McVean
Gilean McVean
Gilean McVean and colleagues report the results of a large-scale clinical genome sequencing project spanning a broad spectrum of disorders. They identify factors influencing successful genetic diagnosis and highlight the challenges of interpreting findings for genetically heterogeneous disorders. To assess factors influencing the success of whole-genome sequencing for mainstream clinical diagnosis, we sequenced 217 individuals from 156 independent cases or families across a broad spectrum of disorders in whom previous screening had identified no pathogenic variants. We quantified the number of candidate variants identified using different strategies for variant calling, filtering, annotation and prioritization. We found that jointly calling variants across samples, filtering against both local and external databases, deploying multiple annotation tools and using familial transmission above biological plausibility contributed to accuracy. Overall, we identified disease-causing variants in 21% of cases, with the proportion increasing to 34% (23/68) for mendelian disorders and 57% (8/14) in family trios. We also discovered 32 potentially clinically actionable variants in 18 genes unrelated to the referral disorder, although only 4 were ultimately considered reportable. Our results demonstrate the value of genome sequencing for routine clinical diagnosis but also highlight many outstanding challenges.

1 February 2012 in Molecular Cell
Verified
Journal Article
Closed access
MKMonika S. Kowalczyk
Monika S. Kowalczyk
JHJim R. Hughes
Jim R. Hughes
DGDavid Garrick
David Garrick
MLMagnus D. Lynch
Magnus D. Lynch
JSJacqueline A. Sharpe
Jacqueline A. Sharpe
DHDouglas R. Higgs
Douglas R. Higgs

1 March 2019 in Molecular Cell
Verified
Journal Article
Open access
ARAlba Rodríguez-Meira
Alba Rodríguez-Meira
GBGemma Buck
Gemma Buck
SCSally-Ann Clark
Sally-Ann Clark
BPBenjamin J. Povinelli
Benjamin J. Povinelli
VAVeronica Alcolea
Veronica Alcolea
AMAdam J. Mead
Adam J. Mead
Single-cell RNA sequencing (scRNA-seq) has emerged as a powerful tool for resolving transcriptional heterogeneity. However, its application to studying cancerous tissues is currently hampered by the lack of coverage across key mutation hotspots in the vast majority of cells; this lack of coverage prevents the correlation of genetic and transcriptional readouts from the same single cell. To overcome this, we developed TARGET-seq, a method for the high-sensitivity detection of multiple mutations within single cells from both genomic and coding DNA, in parallel with unbiased whole-transcriptome analysis. Applying TARGET-seq to 4,559 single cells, we demonstrate how this technique uniquely resolves transcriptional and genetic tumor heterogeneity in myeloproliferative neoplasms (MPN) stem and progenitor cells, providing insights into deregulated pathways of mutant and non-mutant cells. TARGET-seq is a powerful tool for resolving the molecular signatures of genetically distinct subclones of cancer cells.

23 November 2015 in Nature Methods
Verified
Journal Article
Open access
PDF file
JDJames O J Davies
James O J Davies
JTJelena M Telenius
Jelena M Telenius
SMSimon J McGowan
Simon J McGowan
NRNigel A Roberts
Nigel A Roberts
STStephen Taylor
Stephen Taylor
JHJim R Hughes
Jim R Hughes
Pooling barcoded 3C libraries and simultaneously capturing interactions at many loci of interest generates reproducible cis- and trans-interaction maps at high resolution from low amounts of input material. This allows for the comparison of interactions in different cell types using common software designed for differential analysis of sequence count data, rather than requiring software specifically designed for 3C experiments. Methods for analyzing chromosome conformation in mammalian cells are either low resolution or low throughput and are technically challenging. In next-generation (NG) Capture-C, we have redesigned the Capture-C method to achieve unprecedented levels of sensitivity and reproducibility. NG Capture-C can be used to analyze many genetic loci and samples simultaneously. High-resolution data can be produced with as few as 100,000 cells, and single-nucleotide polymorphisms can be used to generate allele-specific tracks. The method is straightforward to perform and should greatly facilitate the investigation of many questions related to gene regulation as well as the functional dissection of traits examined in genome-wide association studies.

1 May 2000 in Molecular Microbiology
Verified
Journal Article
Closed access
PDF file
NTN. R. Thomson
N. R. Thomson
MCM. A. Crow
M. A. Crow
SMS. J. McGowan
S. J. McGowan
ACA. Cox
A. Cox
GSG. P. C. Salmond
G. P. C. Salmond